To view other meetings from ZHL1 choose calendar year:
| Study Section | Panel Name | Meeting Rosters |
|---|---|---|
| ZHL1 CSR-C(S1) | HEAL INITIATIVE: REVERSAL OF OPIOID-INDUCED VENTILATORY DEPRESSION | 06/23/20 |
| ZHL1 CSR-H(O2) | CLINICAL TRIALS SEP | 06/22/20 |
| ZHL1 CSR-B(O1) | NHLBI EMERGING INVESTIGATOR AWARD (EIA) (R35 CLINICAL TRIAL OPTIONAL) | 06/18/20 |
| ZHL1 CSR-P(O1) | NHLBI INSTITUTIONAL TRAINING GRANTS | 05/29/20 |
| ZHL1 CSR-H(O3) | CIRCADIAN DYSFUNCTION AND CARDIOVASCULAR DISEASE RISK | 05/11/20 |
| ZHL1 CCT-Q(C1) | WOMEN'S HEALTH INITIATIVE RENEWAL | 04/30/20 |
| ZHL1 CSR-K(M1) | MENTORED CLINICAL AND BASIC SCIENCE REVIEW COMMITTEE | 04/24/20 |
| ZHL1 CSR-A(M2) | GENETICS OF BLOOD PRESSURE REVIEW | 04/14/20 |
| ZHL1 CSR-M(M2) | GRANT REVIEW FOR NHLBI K AWARD RECIPIENTS (R03) | 04/14/20 |
| ZHL1 CSR-C(M2) | R13 CONFERENCE GRANTS | 04/14/20 |
| ZHL1 CSR-Q(M2) | HLB-SIMPLE: HEART, LUNG, AND BLOOD CO-MORBIDITIES IMPLEMENTATION MODELS IN PEOPLE LIVING WITH HIV | 04/07/20 |
| ZHL1 CSR-Q(M3) | HLB-SIMPLE: HEART, LUNG, AND BLOOD CO-MORBIDITIES IMPLEMENTATION MODELS IN PEOPLE LIVING WITH HIV - RESEARCH COORDINATING CENTER | 04/07/20 |
| ZHL1 CSR-O(M2) | ENABLING TECHNOLOGIES | 04/02/20 |
| ZHL1 CSR-O(M1) | CATALYZE PRODUCT DEFINITION | 04/01/20 |
| ZHL1 CSR-D(M1) | CLINICAL TRIAL IN PEOPLE LIVING WITH HIV | 03/27/20 |
| ZHL1 CSR-I(M1) | DISPARITIES ELIMINATION THROUGH COORDINATED INTERVENTIONS TO PREVENT AND CONTROL HEART AND LUNG DISEASE RISK "DECIPHER" | 03/27/20 |
| ZHL1 CSR-M(M4) | NHLBI MENTORED CAREER DEVELOPMENT AWARDS - K08, K23, K24, K99 | 03/26/20 |
| ZHL1 CSR-B(M1) | PEDIATRIC CARDIAC GENOMICS | 03/25/20 |
| ZHL1 CSR-Q(M1) | K01: CAREER DEVELOPMENT PROGRAM TO PROMOTE DIVERSITY IN HEALTH RESEARCH | 03/24/20 |
| ZHL1 CSR-Z(M1) | MECHANISMS OF IL-1 REGULATION IN AIR POLLUTION-ASSOCIATED CARDIOPULMONARY PATHOLOGY | 03/24/20 |
| ZHL1 CSR-A(M1) | RESEARCH ON IDIOPATHIC PULMONARY FIBROSIS REVIEW | 03/23/20 |
| ZHL1 CSR-M(M3) | NHLBI TOPMED: OMICS PHENOTYPES OF HEART, LUNG, AND BLOOD DISORDERS (X01) | 03/20/20 |
| ZHL1 CSR-M(M1) | TECHNOLOGIES FOR HEALTHY INDEPENDENT LIVING FOR HEART, LUNG, BLOOD AND SLEEP DISORDERS (R43) | 03/19/20 |
| ZHL1 CSR-C(M1) | BLOOD BRAIN BARRIER | 03/19/20 |
| ZHL1 CSR-H(M1) | CLINICAL TRIALS SEP | 03/11/20 |
| ZHL1 CSR-H(M2) | CLINICAL ANCILLARY STUDIES (R01) | 03/10/20 |
| ZHL1 CSR-R(M1) | NHLBI CATALYZE REVIEW FOR SMALL MOLECULES AND BIOLOGICS | 03/09/20 |
| ZHL1 CSR-S(M1) | STIMULATING ACCESS TO RESEARCH IN RESIDENCY TRANSITION SCHOLAR (STARRTS) | 03/06/20 |
| ZHL1 CSR-Z(M2) | CIRCADIAN PATTERNS OF GENE EXPRESSION ASSOCIATED WITH DISEASE | 02/28/20 |
| ZHL1 CSR-Z(M3) | MAXIMIZING THE SCIENTIFIC VALUE OF THE NHLBI BIOREPOSITORY: SCIENTIFIC OPPORTUNITIES FOR EXPLORATORY RESEARCH | 02/20/20 |
| ZHL1 CSR-R(M2) | CARDIOVASCULAR-RENAL OUTCOMES IN PREGNANT WOMEN AND OFFSPRING | 02/13/20 |
| ZHL1 CSR-A(M3) | PULMONARY VASCULAR DISEASE REMODELING REVIEW | 02/12/20 |
| ZHL1 CSR-C(M3) | NEUTROPHIL LINEAGE IN INFLAMMATION | 02/10/20 |
| ZHL1 CCT-I(C1) | TRANSCATHETER TRILEAFLET TRICUSPID SUTURE REPAIR SYSTEM - PHASE II | 01/21/20 |
| ZHL1 CSR-R(M3) | COMPLICATIONS OF HEMOLYSIS AND TRANSFUSION THERAPY | 01/16/20 |
| ZHL1 CCT-R(C2) | TOPIC 110 MRI MYOCARDIAL BIOPSY REVIEW | 01/14/20 |
| ZHL1 CSR-O(F1) | REGENERATIVE MEDICINE 2020 | 01/06/20 |